Xeris Biopharma Holdings, Inc. - COM (XERS)

Historical Holders from Q3 2021 to Q3 2025

Symbol
XERS on Nasdaq
CUSIP
98422E103
Type / Class
Equity / COM
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
96.9M
Holdings value
$789M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
227
Number of buys
133
Number of sells
-87
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Xeris Biopharma Holdings, Inc. - COM (XERS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 96.9M $789M +$58.4M $8.14 227
2025 Q2 90.5M $423M +$16.6M $4.67 200
2025 Q1 86.8M $477M +$124M $5.49 199
2024 Q4 65.6M $222M +$5.69M $3.39 161
2024 Q3 63.9M $182M +$11.7M $2.85 144
2024 Q2 60.6M $136M +$58.6K $2.25 133
2024 Q1 60.5M $134M +$1.1M $2.21 139
2023 Q4 55.9K $131K +$4.77K $2.35 1
2023 Q3 55.3M $103M -$2.38M $1.86 109
2023 Q2 55.9M $147M +$17.8M $2.62 101
2023 Q1 49.5M $80.6M -$5.93M $1.63 89
2022 Q4 53.9M $71.6M -$5.39M $1.33 93
2022 Q3 49M $76.5M -$3.68M $1.56 94
2022 Q2 59.2M $91.1M +$12.1M $1.54 93
2022 Q1 50.4M $129M +$23.9M $2.56 95
2021 Q4 41M $120M +$118M $2.93 83
2021 Q3 704K $1.73M +$1.73M $2.45 1